SunTrust Downgrades Glycomimetics (GLYC) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Glycomimetics (GLYC) PT Lowered to $18 at H.C. Wainwright
August 5, 2019 7:23 AM EDTH.C. Wainwright analyst Edward White lowered the price target on Glycomimetics (NASDAQ: GLYC) to $18.00 (from $23.00) while maintaining a Buy rating.
... MoreGlycoMimetics (GLYC) Announces Pfizer's (PFE) Phase 3 Clinical Trial Evaluating Rivipansel in SCD Did Not Meet Endpoints (Earlier)
August 5, 2019 6:18 AM EDTGlycoMimetics, Inc. (Nasdaq: GLYC) reported that Pfizer Inc. (NYSE: PFE) announced today that the Phase 3 Rivipansel (GMI-1070): Evaluating... More
Glycomimetics (GLYC) PT Lowered to $14 at Stifel
August 5, 2019 2:57 AM EDTStifel analyst Stephen Willey lowered the price target on Glycomimetics (NASDAQ: GLYC) to $14.00 (from $21.00) while maintaining a Buy rating.
... MorePiper Jaffray Downgrades Glycomimetics (GLYC) to Neutral
August 5, 2019 2:56 AM EDTPiper Jaffray analyst Danielle Brill downgraded Glycomimetics (NASDAQ: GLYC) from Overweight to Neutral with a price target of $6.00 (from $20.00).
For an analyst ratings summary and ratings history on Glycomimetics click here. For more ratings news on Glycomimetics click here.
Shares of Glycomimetics closed at $6.00 yesterday.
... More


